HER2-Positive Breast Cancer Shows Strong Immune Response to Single Dose of …

HER2-Positive Breast Cancer Shows Strong Immune Response to Single Dose of …

Case Western University researchers found that a single dose of the anticancer drug trastuzumab induced a strong immune response in HER2-positive breast cancer tumors. Such results confirm previous research suggesting that intrinsic cancer subtype and …

(Visited 2 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.